Ryan Gregg, Ph.D. is a Medical Science Liaison at OneOme. He obtained a B.S. with Honors in Forensic Chemistry from the University of Mississippi, and a Ph.D. in Pharmacology from the Center for Substance Abuse and Research at Temple University School of Medicine. Ryan has a diverse background of experience in pre-clinical and clinical research in psychiatry, hematology, pain, and oncology.
His role at OneOme centers around provider education and training on the utility and benefits of pharmacogenomic testing for the Northeast and Southeast United States, as well as working with physicians, pharmacists, and nurse practitioners to implement pharmacogenomic testing into clinical practice.
OneOme’s RightMed® pharmacogenomic test helps healthcare providers with timely, evidence-based prescription decisions by combining a patient’s genetic profile and current medications in an interactive report that easily integrates into current practices. OneOme’s RightMed test covers cardiovascular disease, cancer, chronic pain, diabetes, psychiatric conditions, and more. The OneOme platform was co-developed and exclusively licensed from Mayo Clinic to bring pharmacogenomics into routine clinical care.
Categories: DPC News